KAT6Aアセチレーションは,AMPK機能と心臓における高縮性再構成を調節する
Mariko Aoyagi Keller1, Andreas Ivessa1, Tong Liu2
1Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers-New Jersey Medical School, 185 South Orange Ave, Newark, NJ 07103, USA.
Molecular metabolism
|August 27, 2025
まとめ
ケトジェニックダイエットは,ミトコンドリア機能と細胞成長に不可欠なKAT6Aアセチレーションを変化させることで,心臓の健康に影響を与えます. このアセチル化がAMPKシグナル伝達に影響し,心臓疾患の治療対象となる可能性がある.
科学分野:
- 心血管生物学
- 代謝の調節
- 分子心臓科
背景:
- ケトジェニックダイエットのような食事の介入は,宿主の代謝と病気の感受性に大きく影響します.
- リスインアセチルトランスフェラーゼ (KAT) は,アセチル-コアを用いた細胞過程の重要な調節体である.
- 前回の研究では,ケトジニックダイエットが心臓病理を緩和することを示しましたが,その背後にあるメカニズムは明らかにする必要があります.
研究 の 目的:
- ケトゲンダイエット条件下での心臓機能と代謝における KAT6A アセチル化の役割を調査する.
- KAT6Aアセチル化とミトコンドリア機能と細胞成長を結びつける分子メカニズムを解明する.
- 心筋細胞におけるAMPKシグナル伝達に対するKAT6A K816アセチル化の影響を決定する.
主な方法:
- ケトゲンダイエットと高血圧のマウス心臓のKAT6Aアセチル化部位を特定するためのプロテオミック分析.
- KAT6Aアセチル化ミメティック変異体が心筋細胞のシグナル伝達に及ぼす影響を評価するためのRNAシーケンシング.
- アセチル化抵抗性のノックインマウスのKAT6A-K816Rの生成と分析
主要な成果:
- KAT6Aのアセチル化が,AMPKサブユニットとの相互作用を高め,ケトゲンダイエット中の心臓で確認された.
- 変異体によって模倣されたKAT6AアセチレーションはAMPKのシグナル伝達を刺激し,心筋細胞のミトコンドリア機能障害と高縮を緩和した.
- KAT6A- K816Rのノックインマウスは,心臓が小さく,AMPK活動が強化され,心臓の改造に対する保護を示しました.
結論:
- K816におけるKAT6Aアセチル化は,ミトコンドリア機能と細胞成長の調節に不可欠である.
- KAT6Aは,K816- アセチル化によってAMPKの活性を調節し,細胞型特異的な方法で心臓代謝と高縮に影響を与えます.
- これらの発見は,KAT6Aアセチル化が,ケトジックダイエットが心臓の健康に与える影響の重要な媒介であることを強調しています.
関連する概念動画
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
Cell Specific Gene Expression
13.9K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K


